CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- 10-KT Report 10-KT
- 8-K Event Other events
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B3 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- S-3 Offering Registration Statement
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 424B3 Offering Prospectus
- 8-K Event Bylaws or fiscal year change
- 8-K Event Delisting notice
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K/A Event Material agreement · Executive or director change
Page 3 of 13 · 258 filings